Two Sigma Investments, LP Biomarin Pharmaceutical Inc Call Options Transaction History

Two Sigma Investments, LP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $8,381 - $9,900	-100 Reduced 0.56%	17,700 $1.55 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $12.7 Million - $16.4 Million	-166,900 Reduced 90.36%	17,800 $1.72 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $6.97 Million - $7.74 Million	-81,900 Reduced 30.72%	184,700 $16.3 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $15 Million - $17.4 Million	173,500 Added 186.36%	266,600 $23.1 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $5.12 Million - $6.85 Million	58,400 Added 168.3%	93,100 $9.05 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $2.81 Million - $3.77 Million	34,700 New	34,700 $3.59 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $22,431 - $25,641	300 Added 6.38%	5,000 $386,000
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $354,897 - $398,513	4,700 New	4,700 $392,000
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $122,179 - $222,751	-1,700 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $318,200 - $496,880	-4,000 Reduced 70.18%	1,700 $210,000
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $142,740 - $193,700	2,000 Added 54.05%	5,700 $482,000
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $936,860 - $1.18 Million	-13,900 Reduced 78.98%	3,700 $249,000
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.17 Million - $1.37 Million	14,600 Added 486.67%	17,600 $1.51 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $240,420 - $318,210	3,000 New	3,000 $255,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.